1. Home
  2. CRC vs CRSP Comparison

CRC vs CRSP Comparison

Compare CRC & CRSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CRC
  • CRSP
  • Stock Information
  • Founded
  • CRC 2014
  • CRSP 2013
  • Country
  • CRC United States
  • CRSP Switzerland
  • Employees
  • CRC N/A
  • CRSP N/A
  • Industry
  • CRC Oil & Gas Production
  • CRSP Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • CRC Energy
  • CRSP Health Care
  • Exchange
  • CRC Nasdaq
  • CRSP Nasdaq
  • Market Cap
  • CRC 4.2B
  • CRSP 4.9B
  • IPO Year
  • CRC N/A
  • CRSP 2016
  • Fundamental
  • Price
  • CRC $56.34
  • CRSP $57.84
  • Analyst Decision
  • CRC Strong Buy
  • CRSP Buy
  • Analyst Count
  • CRC 12
  • CRSP 16
  • Target Price
  • CRC $63.92
  • CRSP $72.27
  • AVG Volume (30 Days)
  • CRC 903.5K
  • CRSP 1.8M
  • Earning Date
  • CRC 11-04-2025
  • CRSP 11-04-2025
  • Dividend Yield
  • CRC 2.74%
  • CRSP N/A
  • EPS Growth
  • CRC 205.84
  • CRSP N/A
  • EPS
  • CRC 7.21
  • CRSP N/A
  • Revenue
  • CRC $3,624,000,000.00
  • CRSP $38,050,000.00
  • Revenue This Year
  • CRC $20.98
  • CRSP N/A
  • Revenue Next Year
  • CRC N/A
  • CRSP $348.18
  • P/E Ratio
  • CRC $7.84
  • CRSP N/A
  • Revenue Growth
  • CRC 60.00
  • CRSP N/A
  • 52 Week Low
  • CRC $30.97
  • CRSP $30.04
  • 52 Week High
  • CRC $60.41
  • CRSP $71.13
  • Technical
  • Relative Strength Index (RSI)
  • CRC 72.30
  • CRSP 58.47
  • Support Level
  • CRC $48.84
  • CRSP $51.63
  • Resistance Level
  • CRC $52.97
  • CRSP $55.59
  • Average True Range (ATR)
  • CRC 1.64
  • CRSP 2.17
  • MACD
  • CRC 0.54
  • CRSP 0.47
  • Stochastic Oscillator
  • CRC 85.17
  • CRSP 90.22

About CRC California Resources Corporation

California Resources Corp is an independent oil and natural gas exploration and production company operating properties exclusively within California. It provides affordable and reliable energy in a safe and responsible manner, to support and enhance the quality of life of Californians and the local communities in which the company operates. It has some of the lowest carbon intensity production in the United States and is focused on maximizing the value of its land, mineral, and technical resources for decarbonization by developing carbon capture and storage (CCS) and other emissions-reducing projects.

About CRSP CRISPR Therapeutics AG

Crispr Therapeutics is a gene editing company focused on the development of Crispr/Cas9-based therapeutics. Crispr/Cas9 stands for clustered regularly interspaced short palindromic repeats (Crispr)/Crispr-associated protein 9 (Cas9), which is a revolutionary technology for precisely altering specific sequences of genomic DNA. The company is focused on using this technology to treat genetically defined diseases. Crispr's first approved drug is Casgevy, which was developed in collaboration with Vertex Pharmaceuticals and targets sickle-cell disease and transfusion-dependent beta-thalassemia, which have high unmet medical needs. The company is advancing a variety of gene editing programs in immuno-oncology, cardiovascular, and a stem cell-derived therapy to treat Type 1 diabetes.

Share on Social Networks: